Calbindin-D28k (CaBP), a calcium-binding protein that is present in defined neuronal populations in the brain and spinal cord, appears to protect cells from calcium-mediated cellular degeneration. CaBP is found in the hippocampal neurons that are spared cell loss caused by experimentally induced seizures and excitotoxins. The neurons that do not contain CaBP appear to die as a result of toxic levels of intracellular Ca2+. Recent data from our laboratory indicate that the specific midbrain dopaminergic (DA) neurons that contain CaBP are preserved in patients with Parkinson's disease, and in monkeys and mice treated with 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, a neurotoxin which produces a parkinsonian syndrome). However, those DA neurons that do not contain CaBP are most vulnerable to Parkinson's disease and MPTP. The purpose of the present grant is-to determine whether CaBP protects midbrain DA neurons from the neurotoxic effects of MPTP in the mouse. First, we will use immunohistochemical staining for CaBP, computer imaging, CaBP in situ hybridization, 14C-MPTP in vivo autoradiography, and monoamine biochemical measuring techniques to determine whether endogenous CaBP protects specific midbrain DA neurons from MPTP-induced degeneration. Secondly, we will develop animal models in which to test the protective effects of CaBP against MPTP by generating transgenic mice which express CaBP within all of the midbrain DA neurons. We will use the tyrosine hydroxylase promoter and the neuron specific enolase promoter to ex-press CaBP, and determine whether the presence of this protein will specifically protect MPTP-sensitive areas of the midbrain (substantia nigra). These experiments will: (I) determine whether CaBP protects midbrain DA neurons from MPTP-induced parkinsonism; and (2) provide animal models of other neurodegenerative diseases where calcium-mediated neurodegeneration may play a major etiologic role (e.g., Alzheimer's disease, Huntington's disease).

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS030406-02
Application #
2268394
Study Section
Neurology A Study Section (NEUA)
Project Start
1993-08-01
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
McMahon, A; Wong, B S; Iacopino, A M et al. (1998) Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells. Brain Res Mol Brain Res 54:56-63
Speciale, S G; Liang, C L; Sonsalla, P K et al. (1998) The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter. Neuroscience 84:1177-85
Sanghera, M K; Manaye, K; McMahon, A et al. (1997) Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP. Neuroreport 8:3327-31
Sonsalla, P K; Manzino, L; Sinton, C M et al. (1997) Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra. Brain Res 773:223-6
German, D C; Ng, M C; Liang, C L et al. (1997) Calbindin-D28k in nerve cell nuclei. Neuroscience 81:735-43
McMahon, A; Lephart, E D; Chi, S et al. (1996) Calbindin-D28K in the nucleus of nerve growth factor-treated PC12 cells. Neuroreport 7:2419-22
Liang, C L; Sinton, C M; German, D C (1996) Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin. Neuroscience 75:523-33
Nelson, E L; Liang, C L; Sinton, C M et al. (1996) Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J Comp Neurol 369:361-71
German, D C; Nelson, E L; Liang, C L et al. (1996) The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration 5:299-312
Liang, C L; Sinton, C M; Sonsalla, P K et al. (1996) Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration 5:313-8

Showing the most recent 10 out of 14 publications